Author/Creator: Hwang, P. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Hwang, P.

1. Efficacy and safety of grazoprevir + ribavirin for 12 or 24 weeks in treatment‐naïve patients with hepatitis C virus genotype 1 infection. Issue 10 (12th June 2016)

Authors:: Gane, E.; Ben Ari, Z.; Mollison, L.; Zuckerman, E.; Bruck, R.; Baruch, Y.; Howe, A. Y. M.; Wahl, J.; Bhanja, S.; Hwang, P.; Zhao, Y.; Robertson, M. N.
Journal:: Journal of viral hepatitis
Issue:: Volume 23:Issue 10(2016)
Page Start:: 789
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment‐naïve, noncirrhotic HCV genotype 3‐infected patients. Issue 10 (23rd June 2017)

Authors:: Gane, E.; Nahass, R.; Luketic, V.; Asante‐Appiah, E.; Hwang, P.; Robertson, M.; Wahl, J.; Barr, E.; Haber, B.
Journal:: Journal of viral hepatitis
Issue:: Volume 24:Issue 10(2017)
Page Start:: 895
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Grazoprevir plus peginterferon and ribavirin in treatment‐naive patients with hepatitis C virus genotype 1 infection: a randomized trial. Issue 2 (10th September 2015)

Authors:: Lagging, M.; Brown, A.; Mantry, P. S.; Ramji, A.; Weilert, F.; Vierling, J. M.; Howe, A.; Gendrano, I. N.; Hwang, P.; Zhang, B.; Wahl, J.; Robertson, M.; Mobashery, N.
Journal:: Journal of viral hepatitis
Issue:: Volume 23:Issue 2(2016)
Page Start:: 80
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗